Press releases
All articles
-
Angelini Pharma and Trueblue: a new collaboration gets underway for optimising data-based decision making and analytics
Promoting the development of corporate decision-making process powered by the use of data.
-
Ovid Therapeutics and Angelini Pharma
Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 for the Treatment of Angelman Syndrome in Europe.
-
Rosita Calabrese is the new Country Manager Italy
In her role she will report to CEO Pierluigi Antonelli and will be part of the Executive Leadership Team, the Company's Steering Committee.
-
Enza Onnis, Global Pharma General Counsel at Angelini Pharma
In her role she will report to CEO Pierluigi Antonelli and will continue to be part of the Executive Leadership Team, Angelini Pharma’s steering committee, which she joined in April 2019.
-
Andrè Kindling, new Country Manager Germany
In his role, Kindling will be directly reporting to Luigi Cianci, Chief Commercial Officer – International.
-
Angelini Pharma launches “LA GRANDE INCERTEZZA”, a podcast devoted to the psychological challenges of this epochal period
La grande incertezza” is also a multi-channel communication campaign.
-
Angelini Foundation in support of Lazzaro Spallanzani Hospital in the fight against Coronavirus
The 1 million euros donation will reinforce research laboratories where COVID-19 was isolated in Italy for the first time.
-
Angelini Pharma on the front lines against COVID-19
Angelini Pharma remains mobilized in the fight against the spread of COVID-19 to protect our doctors, nurses, medical workers on the front lines and all Italians. With Italy. For Italy.
-
Angelini Pharma acquires ThermaCare from GSK
Angelini Pharma announces today it has acquired the ThermaCare® global business rights, excluding North America, from GSK. The deal also includes the dedicated US manufacturing site for ThermaCare in Albany, Georgia.
-
-
Daniela Poggio Global Communications Head at Angelini Pharma
Daniela Poggio is joining Angelini Pharma in the new role of Global Communications Head, reporting directly to CEO Pierluigi Antonelli.
-
Fabio De Luca Chief Marketing Officer at Angelini Pharma
With his many years of experience in roles of increasing responsibility in multinationals (Wyeth, Abbott, Bristol-Myers Squibb) as well as leading Italian companies (Chiesi), Fabio De Luca is now taking the helm of Global Marketing at Angelini Pharma, having successfully strengthened our Italian business in the Prescription Medication and Consumer Healthcare sectors.
-
Angelini Announces close of acquisition of two Sanofi consumer healthcare products in Germany and Austria
Angelini Pharma announces the acquisition of two Sanofi CHC brands in Germany and Austria for a total of € 47 M.
-
Sumitomo Dainippon Pharma and Angelini announce partnership for commercialization of Latuda in Europe
Sumitomo Dainippon Pharma Co., Ltd. and Angelini S.p.A. announced today that the companies have formed a partnership with the goal to expand availability in Europe of Latuda®, an atypical antipsychotic.
-
Angelini announces the launch on the Italian market of an innovative active wound cleanser developed by the Swiss company APR
The new acid-oxidising solution containing hypochlorous acid and intended for cleansing various kind of wounds, including diabetic foot ulcers, pressure and vascular ulcers, has arrived in Italy.
-
The project “Psychè” is set up in order to train the family doctor
Depression affects 7.5 million people, namely 12.5% of the population in Italy. According to the World Health Organisation (WHO), this illness is the first reason for disability nowadays.
-
